Unknown

Dataset Information

0

Acceptability of patient-centered, multi-disciplinary medication therapy management recommendations: results from the INCREASE randomized study.


ABSTRACT:

Background

Polypharmacy and inappropriate medications may be a modifiable risk factor for Alzheimer's Disease and Related Dementias (ADRD). Medication therapy management (MTM) interventions may mitigate medication-induced cognitive dysfunction and delay onset of symptomatic impairment. The objective of the current study is to describe an MTM protocol for a patient-centered team intervention (pharmacist and non-pharmacist clinician) in a randomized controlled trial (RCT) directed at delaying the symptomatic onset of ADRD.

Methods

Community dwelling adults 65 + years, non-demented, using ≥ 1 potentially inappropriate medications (PIM) were enrolled in an RCT to evaluate the effect of an MTM intervention on improving medication appropriateness and cognition (NCT02849639). The MTM intervention involved a three-step process: (1) pharmacist identified potential medication-related problems (MRPs) and made initial recommendations for prescribed and over-the-counter medications, vitamins, and supplements; (2) study team reviewed all initial recommendations together with the participants, allowing for revisions prior to the finalized recommendations; (3) participant responses to final recommendations were recorded. Here, we describe initial recommendations, changes during team engagement, and participant responses to final recommendations.

Results

Among the 90 participants, a mean 6.7 ± 3.6 MRPs per participant were reported. Of the 259 initial MTM recommendations made for the treatment group participants (N = 46), 40% percent underwent revisions in the second step. Participants reported willingness to adopt 46% of final recommendations and expressed need for additional primary care input in response to 38% of final recommendations. Willingness to adopt final recommendations was highest when therapeutic switches were offered and/or with anticholinergic medications.

Conclusion

The evaluation of modifications to MTM recommendations demonstrated that pharmacists' initial MTM recommendations often changed following the participation in the multidisciplinary decision-making process that incorporated patient preferences. The team was encouraged to see a correlation between engaging patients and a positive overall response towards participant acceptance of final MTM recommendations.

Trial registration

Study registration number: clinicaltrial.gov NCT02849639 registered on 29/07/2016.

SUBMITTER: Smith NI 

PROVIDER: S-EPMC9999619 | biostudies-literature | 2023 Mar

REPOSITORIES: biostudies-literature

altmetric image

Publications

Acceptability of patient-centered, multi-disciplinary medication therapy management recommendations: results from the INCREASE randomized study.

Smith Noah I NI   Martinez Ashley I AI   Huffmyer Mark M   Eckmann Lynne L   George Rosmy R   Abner Erin L EL   Jicha Gregory A GA   Moga Daniela C DC  

BMC geriatrics 20230310 1


<h4>Background</h4>Polypharmacy and inappropriate medications may be a modifiable risk factor for Alzheimer's Disease and Related Dementias (ADRD). Medication therapy management (MTM) interventions may mitigate medication-induced cognitive dysfunction and delay onset of symptomatic impairment. The objective of the current study is to describe an MTM protocol for a patient-centered team intervention (pharmacist and non-pharmacist clinician) in a randomized controlled trial (RCT) directed at delay  ...[more]

Similar Datasets

| S-EPMC6980369 | biostudies-literature
| S-EPMC10322126 | biostudies-literature
| S-EPMC9178508 | biostudies-literature
| S-EPMC5499346 | biostudies-other
| S-EPMC5830099 | biostudies-literature
| S-EPMC5496371 | biostudies-literature
| S-EPMC6053609 | biostudies-literature
| S-EPMC6027458 | biostudies-literature
| S-EPMC7376007 | biostudies-literature
| S-EPMC9463860 | biostudies-literature